The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Parker David L since year 2005.
The trader's CIK number is 1192602.
At the time of this reporting, Parker David L is the Vice President of Introgen Therapeutics Inc .
(stock ticker symbol INGN).
See this page for all insider trading activities at Introgen Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2007-12-20||INGN||Introgen Therapeutics Inc||Option Ex||20,000||.52||10,380|
|2006-09-05||INGN||Introgen Therapeutics Inc||Option Ex||15,000||.52||7,785|
|2005-12-30||INGN||Introgen Therapeutics Inc||Option Ex||15,000||.52||7,785|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Parker David L (Vice President of Introgen Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.